Investigators assessed disparities in IBD clinical trials regarding a lack of inclusion of pregnant, lactating women; older adults; and racial and ethnic minorities.
Investigators examined whether a patient’s initial response to anti-tumor necrosis factor (TNF)-a antibody could inform subsequent treatment in ulcerative colitis.
Researchers sought to identify factors that could help predict postoperative opioid consumption in patients with IBD.
Researchers compared the difference in overall health care utilization in patients with IBD who started anti-TNF therapy 2 years vs more than 2 years postdiagnosis.
A team of researchers assessed histologic activity in patients with ulcerative colitis who were in endoscopic and clinical remission, using the NHI score to predict future relapse.
Researchers sought to determine the prevalence of polypharmacy in adults with Crohn disease and ulcerative colitis, collectively referred to as IBD.
Researchers examined the efficacy of higher adalimumab induction and maintenance dose regimens in adults with ulcerative colitis.
Researchers sought to create a histological index that would help evaluate inflammation and predict clinical outcomes in patients with ulcerative colitis.
Researchers sought to identify the equivalent C-reactive protein cutoff for an erythrocyte sedimentation rate greater than 30 mm/h in severe UC.
For patients with ulcerative colitis, large, unresected, multifocal low-grade dysplasia and recent moderate/severe histological inflammation are associated with elevated risk of developing advanced neoplasia.
Investigators compared the safety and efficacy of different ambulatory care pathways vs traditional inpatient care in patients with acute severe ulcerative colitis.
Researchers assessed clinical predictors for a complicated disease course in patients recently diagnosed with ulcerative colitis.
Researchers assessed the association between CRP-to-albumin ratio and ulcerative colitis regarding clinical remission, mucosal healing, and endoscopic disease severity.
The PAS is supported by data from the REFLECTIONS B538-12 study, which assessed multiple switches between Abrilada and Humira, in addition to methotrexate, in adults with moderate to severe rheumatoid arthritis.
Investigators assessed geographic and longitudinal trends in the incidence and prevalence of pediatric-onset inflammatory bowel disease.
Investigators assessed whether changes in fecal calprotectin levels better predict achievement of remission than levels at diagnosis in children with ulcerative colitis.
A C-reactive protein cutoff is a sensitive and practical alternative to erythrocyte sedimentation rate as a criterion to help determine ulcerative colitis activity.
Investigators assessed the relationship between physical activity, body mass index, and body composition among pediatric patients with inflammatory bowel disease.
Investigators ranked the efficacy and safety of biological and small molecule treatments for moderate to severe ulcerative colitis.
Investigators highlight the burdens caused by unaddressed or uncontrolled symptoms of IBD and suggest ways physicians could address these burdens in clinical practice.